Cipla Ltd.

₹1473

+ 7.00 (0.48%)

04:01 pm - close price

BSE: CIPLA

NSE: CIPLA

Industry: Pharmaceuticals & Drugs

House: Cipla

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 48.02Good: 5

✅

Adjusted EPS

Bad: 3Current: 48.02Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 16.00Good: 20

🟡

Current Ratio

Bad: 1Current: 3.44Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 11.83Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 0.62Good: 0.5

🟡

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 48.02Good: 5

✅

Adjusted EPS

Bad: 3Current: 48.02Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 16.00Good: 20

🟡

Current Ratio

Bad: 1Current: 3.44Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 11.83Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 0.62Good: 0.5

🟡

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	0	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	6678.15	6603.81	6163.24	6693.94
Expenditure+	4944.40	4856.28	4847.38	4978.14
Other Income+	176.32	184.63	249.33	160.19
Operating Profit	1733.75	1747.53	1315.86	1715.80
Interest	25.80	30.10	17.59	17.95
Depreciation and Amortization	290.04	233.43	288.34	246.68
Profit Before Tax	1593.78	1473.71	1256.73	1610.53
Tax+	438.41	405.30	324.86	435.07
Net Profit	1155.37	1068.41	931.87	1175.46

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	21763.34	22753.12	25774.09	27547.62	28162.59
Operational Expenses+	17251.38	17762.83	19483.04	20424.78	22279.69
Operating Profit	4511.96	4990.29	6291.05	7122.84	5882.90
Other Income	321.73	512.13	746.57	866.93	882.01
OPM %	20.73	21.93	24.41	25.86	20.89
Depreciation and Amortisation	1051.95	1172.11	1051.02	1106.95	1210.98
Interest	106.35	109.54	89.88	62.01	54.39
Profit Before Tax	3493.27	4038.35	5701.90	6820.81	5223.63
Tax	921.70	1189.15	1539.11	1682.52	1379.37
Net Profit	2516.75	2801.91	4121.55	5272.52	3879.23

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	26652.29	29006.74	32130.02	36742.17	41594.96
Liabilities+	26652.29	28930.34	32130.02	36742.17	41594.96

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	3325.90	3237.65	4133.91	5004.98	3940.02
Cash from Investing Activity	-1871.88	-2388.51	-2988.03	-3691.14	-2326.13
Cash from Financing Activity	-1599.79	-958.29	-1200.43	-1292.79	-1233.65
Net Cash Flow	-145.77	-109.15	-54.55	21.05	380.24
Opening Cash & Cash Equivalents	790.43	658.11	561.33	512.34	542.65
Closing Cash & Cash Equivalents	658.11	561.33	512.34	542.65	1015.39

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	29.21	29.21	29.21	29.21	29.19	29.20	29.19	30.92	30.91	33.47
Public+	70.79	70.79	70.79	70.79	70.81	70.80	70.81	69.08	69.09	66.53
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	578679	584217	540521	534587	549655	543420	525114	470234	463569	436154

Corporate Actions

275 events in the last 3 years

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	3325.90	3237.65	4133.91	5004.98	3940.02
Cash from Investing Activity	-1871.88	-2388.51	-2988.03	-3691.14	-2326.13
Cash from Financing Activity	-1599.79	-958.29	-1200.43	-1292.79	-1233.65
Net Cash Flow	-145.77	-109.15	-54.55	21.05	380.24
Opening Cash & Cash Equivalents	790.43	658.11	561.33	512.34	542.65
Closing Cash & Cash Equivalents	658.11	561.33	512.34	542.65	1015.39

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	21763.34	22753.12	25774.09	27547.62	28162.59
Operational Expenses+	17251.38	17762.83	19483.04	20424.78	22279.69
Operating Profit	4511.96	4990.29	6291.05	7122.84	5882.90
Other Income	321.73	512.13	746.57	866.93	882.01
OPM %	20.73	21.93	24.41	25.86	20.89
Depreciation and Amortisation	1051.95	1172.11	1051.02	1106.95	1210.98
Interest	106.35	109.54	89.88	62.01	54.39
Profit Before Tax	3493.27	4038.35	5701.90	6820.81	5223.63
Tax	921.70	1189.15	1539.11	1682.52	1379.37
Net Profit	2516.75	2801.91	4121.55	5272.52	3879.23

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	6678.15	6603.81	6163.24	6693.94
Expenditure+	4944.40	4856.28	4847.38	4978.14
Other Income+	176.32	184.63	249.33	160.19
Operating Profit	1733.75	1747.53	1315.86	1715.80
Interest	25.80	30.10	17.59	17.95
Depreciation and Amortization	290.04	233.43	288.34	246.68
Profit Before Tax	1593.78	1473.71	1256.73	1610.53
Tax+	438.41	405.30	324.86	435.07
Net Profit	1155.37	1068.41	931.87	1175.46

Ratios

Reported EPS

Bad: 2Current: 48.02Good: 5

✅

Adjusted EPS

Bad: 3Current: 48.02Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 16.00Good: 20

🟡

Current Ratio

Bad: 1Current: 3.44Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 11.83Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 0.62Good: 0.5

🟡

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 48.02Good: 5

✅

Adjusted EPS

Bad: 3Current: 48.02Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 16.00Good: 20

🟡

Current Ratio

Bad: 1Current: 3.44Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 11.83Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 0.62Good: 0.5

🟡

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	26652.29	29006.74	32130.02	36742.17	41594.96
Liabilities+	26652.29	28930.34	32130.02	36742.17	41594.96

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	0	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	29.21	29.21	29.21	29.21	29.19	29.20	29.19	30.92	30.91	33.47
Public+	70.79	70.79	70.79	70.79	70.81	70.80	70.81	69.08	69.09	66.53
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	578679	584217	540521	534587	549655	543420	525114	470234	463569	436154

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Cipla Ltd.

₹1473

+ 7.00 (0.48%)

04:01 pm - close price

BSE: CIPLA

NSE: CIPLA

Industry: Pharmaceuticals & Drugs

House: Cipla

Overview

Corporate Actions

275 events in the last 3 years